Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression

by Loebel, Antony, Citrome, Leslie
Published 2015

Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia

by Rajagopalan, Krithika, Trueman, David, Crowe, Lydia, Squirrell, Daniel, Loebel, Antony
Published 2016

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

by O’Day, Ken, Rajagopalan, Krithika, Meyer, Kellie, Pikalov, Andrei, Loebel, Antony
Published 2013

Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia

by Awad, George, Hassan, Mariam, Loebel, Antony, Hsu, Jay, Pikalov, Andrei, Rajagopalan, Krithika
Published 2014

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia

by Loebel, Antony D., Siu, Cynthia O., Cucchiaro, Josephine B., Pikalov, Andrei A., Harvey, Philip D.
Published 2013

Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies

by Nasrallah, Henry A., Cucchiaro, Josephine B., Mao, Yongcai, Pikalov, Andrei A., Loebel, Antony D.
Published 2014

LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY

by Ketter, Terence A., Sarma, Kaushik, Silva, Robert, Kroger, Hans, Cucchiaro, Josephine, Loebel, Antony
Published 2016

Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults

by Koblan, Kenneth S, Hopkins, Seth C, Sarma, Kaushik, Jin, Fengbin, Goldman, Robert, Kollins, Scott H, Loebel, Antony
Published 2015

Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation

by Loebel, Antony, Citrome, Leslie, Correll, Christoph U., Xu, Jane, Cucchiaro, Josephine, Kane, John M.
Published 2015

Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia

by Meyer, Jonathan M., Mao, Yongcai, Pikalov, Andrei, Cucchiaro, Josephine, Loebel, Antony
Published 2015

A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

by Tandon, Rajiv, Cucchiaro, Josephine, Phillips, Debra, Hernandez, David, Mao, Yongcai, Pikalov, Andrei, Loebel, Antony
Published 2016

Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults

by Hopkins, Seth C., Sunkaraneni, Soujanya, Skende, Estela, Hing, Jeremy, Passarell, Julie A., Loebel, Antony, Koblan, Kenneth S.
Published 2015

The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial

by Rajagopalan, Krithika, Bacci, Elizabeth Dansie, Wyrwich, Kathleen W., Pikalov, Andrei, Loebel, Antony
Published 2016

Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia

by Awad, George, Ng-Mak, Daisy, Rajagopalan, Krithika, Hsu, Jay, Pikalov, Andrei, Loebel, Antony
Published 2016

Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials

by Rajagopalan, Krithika, Bacci, Elizabeth Dansie, Ng-Mak, Daisy, Wyrwich, Kathy, Pikalov, Andrei, Loebel, Antony
Published 2016

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

by Loebel, Antony, Brams, Matthew, Goldman, Robert S., Silva, Robert, Hernandez, David, Deng, Ling, Mankoski, Raymond, Findling, Robert L.
Published 2015

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

by Citrome, Leslie, Weiden, Peter J, McEvoy, Joseph P, Correll, Christoph U., Cucchiaro, Josephine, Hsu, Jay, Loebel, Antony
Published 2013

A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State

by Patkar, Ashwin, Gilmer, William, Pae, Chi-un, Vöhringer, Paul A., Ziffra, Michael, Pirok, Edward, Mulligan, Molly, Filkowski, Megan M., Whitham, Elizabeth A., Holtzman, Niki S., Thommi, Sairah B., Logvinenko, Tanya, Loebel, Antony, Masand, Prakash, Ghaemi, S. Nassir
Published 2012

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia

by Keefe, Richard S. E., Haig, George M., Marder, Stephen R., Harvey, Philip D., Dunayevich, Eduardo, Medalia, Alice, Davidson, Michael, Lombardo, Ilise, Bowie, Christopher R., Buchanan, Robert W., Bugarski-Kirola, Dragana, Carpenter, William T., Csernansky, John T., Dago, Pedro L., Durand, Dante M., Frese, Frederick J., Goff, Donald C., Gold, James M., Hooker, Christine I., Kopelowicz, Alex, Loebel, Antony, McGurk, Susan R., Opler, Lewis A., Pinkham, Amy E., Stern, Robert G.
Published 2016